Analyst Downgrades: Netflix, Inc., Potash Corporation of Saskatchewan, and Illumina, Inc.

Analysts downwardly revised their ratings and price targets on Netflix, Inc. (NASDAQ:NFLX), Potash Corporation of Saskatchewan (USA) (NYSE:POT), and Illumina, Inc. (NASDAQ:ILMN)

by Josh Selway

Published on Apr 19, 2016 at 9:14 AM

Analysts are weighing in on streaming video provider Netflix, Inc. (NASDAQ:NFLX), fertilizer firm Potash Corporation of Saskatchewan (USA) (NYSE:POT), and genetic analysis stock Illumina, Inc. (NASDAQ:ILMN). Here's a quick roundup of today's bearish brokerage notes on NFLX, POT, and ILMN.

  • NFLX is off 8.5% ahead of the open after the company's first-quarter earnings release. While quarterly profit beat forecasts and revenue met expectations, Netflix, Inc.'s current-quarter subscriber growth outlook disappointed. NFLX has added close to 34% in the past 12 months to trade at $108.40, but is now set to open back below the century level. This potential price action is likely to disappoint bullish options traders. Making matters worse, analysts are trimming their expectations in a hurry. No fewer than seven brokerage firms cut their price targets on NFLX this morning, though the lowest of which -- from Baird -- came in at just $108. 
  • POT is so far unchanged in electronic trading, despite a bearish note from Barclays. The brokerage firm dropped the stock's rating to "underweight" from "equal weight," while reducing its price target to $14 from $16. The shares have been moving steadily lower for the past year, hitting a nine-year low of $14.64 in January, and closing Monday at $16.76. Most other analysts share Barclays' grim outlook. Specifically, 13 of 18 covering analysts call Potash Corporation of Saskatchewan (USA) a "hold" or worse. 
  • ILMN is getting crushed in pre-market trading, down 19.2%, after the company's preliminary first-quarter revenue results came in well below the Street's expectations. At $178.13, Illumina, Inc. is a far cry from its all-time high of $242.37, seen last July, but the stock just yesterday managed its first close atop its 200-day moving average this year. Regardless, BofA-Merrill Lynch cut its rating on ILMN to "neutral" this morning, while Goldman Sachs, Barclays, Cowen, and Leerink all lowered their price targets. The pending sell-off should benefit options traders at the International Securities Exchange (ISE), Chicago Board Options Exchange (CBOE), and NASDAQ OMX PHLX (PHLX), however. The stock's 10-day put/call volume ratio across these exchanges sits at 1.26, in the 69th percentile of its annual range. 
Sign up now for Schaeffer's Opening View newsletter to get a head start on all the major pre-market news!

a schaeffer's exclusive

PLAY TRENDS LIKE A PRO!

5 tips to leverage profits in this FREE insider report!


 
 

Partnercenter


NEW! Explore Schaeffer’s Partners' deals and get connected to top online brokerages with deals tailored exclusively for our readers.  Get answers to your questions regarding transfer fees, commission rates, programs and available discounts related to online trading services.

MORE | MARKETstories


The Trend Minting Millionaires -- But Who Is Really Paying?
Porter Stansberry is making a concerning prediction.
Wall Street Reacts to Fed Decision, Trade Deal
Investors waited and reacted to the Fed decision and trade headlines
Sarepta Therapeutics Stock Eyes Best Day in 3 Years on FDA Reversal
SRPT is buzzing on the FDA's change of heart
The Trend Minting Millionaires -- But Who Is Really Paying?
Porter Stansberry is making a concerning prediction.